BG104726A - Novel derivatives of the dihydroxyhexanoic acid - Google Patents

Novel derivatives of the dihydroxyhexanoic acid

Info

Publication number
BG104726A
BG104726A BG104726A BG10472600A BG104726A BG 104726 A BG104726 A BG 104726A BG 104726 A BG104726 A BG 104726A BG 10472600 A BG10472600 A BG 10472600A BG 104726 A BG104726 A BG 104726A
Authority
BG
Bulgaria
Prior art keywords
novel derivatives
dihydroxyhexanoic acid
dihydroxyhexanoic
acid
derivatives
Prior art date
Application number
BG104726A
Other languages
Bulgarian (bg)
English (en)
Inventor
John KATH
Matthew Brown
Christopher POSS
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG104726A publication Critical patent/BG104726A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
BG104726A 1998-02-05 2000-08-29 Novel derivatives of the dihydroxyhexanoic acid BG104726A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05
PCT/IB1999/000067 WO1999040061A2 (en) 1998-02-05 1999-01-18 Novel dihydroxyhexanoic acid derivatives

Publications (1)

Publication Number Publication Date
BG104726A true BG104726A (en) 2001-04-30

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104726A BG104726A (en) 1998-02-05 2000-08-29 Novel derivatives of the dihydroxyhexanoic acid

Country Status (37)

Country Link
EP (1) EP1051405B1 (no)
JP (1) JP3693916B2 (no)
KR (1) KR100385529B1 (no)
CN (1) CN1177834C (no)
AP (1) AP992A (no)
AR (1) AR016175A1 (no)
AT (1) ATE337307T1 (no)
AU (1) AU752407B2 (no)
BG (1) BG104726A (no)
BR (1) BR9907655A (no)
CA (1) CA2320388C (no)
DE (1) DE69932920T2 (no)
DZ (1) DZ2717A1 (no)
EA (1) EA003137B1 (no)
ES (1) ES2268847T3 (no)
GT (1) GT199900011A (no)
HK (1) HK1034969A1 (no)
HR (1) HRP20000529B1 (no)
HU (1) HUP0100832A3 (no)
IL (1) IL137330A0 (no)
IS (1) IS5562A (no)
MA (1) MA26603A1 (no)
MY (1) MY133125A (no)
NO (1) NO20003965D0 (no)
NZ (1) NZ505724A (no)
OA (1) OA11448A (no)
PA (1) PA8467301A1 (no)
PE (1) PE20000243A1 (no)
PL (1) PL342817A1 (no)
SK (1) SK11262000A3 (no)
TN (1) TNSN99013A1 (no)
TR (1) TR200002248T2 (no)
TW (1) TW470744B (no)
UA (1) UA57824C2 (no)
WO (1) WO1999040061A2 (no)
YU (1) YU47100A (no)
ZA (1) ZA99873B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002535358A (ja) * 1999-01-29 2002-10-22 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 移植片拒絶反応及び虚血−再灌流障害の予防方法
BR0013469B1 (pt) * 1999-08-20 2011-01-25 amidas aromáticas heterocìclicas fungicidas, composição fungicida compreendendo as mesmas, bem como método para o controle ou a prevenção de infestação fúngica.
KR20020072304A (ko) * 2000-02-04 2002-09-14 화이자 프로덕츠 인코포레이티드 헤테로사이클릭 아미드 유도체
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
DE60233874D1 (de) * 2001-06-22 2009-11-12 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
BR0210519A (pt) 2001-06-22 2004-06-22 Pfizer Prod Inc Composições farmacêuticas de adsorvatos de fármaco amorfo
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
BR0307344A (pt) 2002-02-01 2004-12-14 Pfizer Prod Inc Composições farmacêuticas de dispersões amorfas de fármacos e materiais formadores de microfase lipofìlica
KR20050006256A (ko) * 2002-05-14 2005-01-15 화이자 프로덕츠 인크. 디히드록시헥산산 유도체, 이들의 중간체, 및 제조 방법
WO2003095439A1 (en) * 2002-05-14 2003-11-20 Pfizer Products Inc. Methods for manufacture of dihydro-furan-2-one derivatives
CA2494776A1 (en) * 2002-08-12 2004-02-19 Pfizer Products Inc. Crystal forms of quinoxaline-2-carboxylic acid ¬4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl|-amide
RU2005103625A (ru) 2002-08-12 2005-08-20 Пфайзер Продактс Инк. (Us) Фармацевтические композиции полуупорядоченных лекарств и полимеров
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
ES2180600T3 (es) * 1994-10-19 2003-02-16 Novartis Ag Eteres de isosteros substrato de aspartato proteasa antivirales.
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
EP1051405B1 (en) 2006-08-23
ZA99873B (en) 2000-08-04
JP2002502839A (ja) 2002-01-29
DZ2717A1 (fr) 2003-09-01
AP992A (en) 2001-08-06
JP3693916B2 (ja) 2005-09-14
WO1999040061A3 (en) 1999-10-21
HRP20000529B1 (en) 2004-12-31
IS5562A (is) 2000-07-14
EP1051405A2 (en) 2000-11-15
NO20003965L (no) 2000-10-03
TR200002248T2 (tr) 2000-12-21
BR9907655A (pt) 2000-10-24
CN1290255A (zh) 2001-04-04
EA003137B1 (ru) 2003-02-27
KR100385529B1 (ko) 2003-05-27
PE20000243A1 (es) 2000-04-07
NO20003965D0 (no) 2000-08-04
HK1034969A1 (en) 2001-11-09
WO1999040061A2 (en) 1999-08-12
GT199900011A (es) 2000-07-20
DE69932920D1 (de) 2006-10-05
AU752407B2 (en) 2002-09-19
YU47100A (sh) 2002-11-15
OA11448A (en) 2003-11-18
AR016175A1 (es) 2001-06-20
HRP20000529A2 (en) 2001-08-31
AP9901457A0 (en) 1999-03-31
PA8467301A1 (es) 2000-05-24
SK11262000A3 (sk) 2001-01-18
HUP0100832A3 (en) 2002-03-28
KR20010040684A (ko) 2001-05-15
PL342817A1 (en) 2001-07-02
CA2320388A1 (en) 1999-08-12
MA26603A1 (fr) 2004-12-20
AU1778999A (en) 1999-08-23
TW470744B (en) 2002-01-01
NZ505724A (en) 2003-02-28
TNSN99013A1 (fr) 2005-11-10
CA2320388C (en) 2005-05-03
DE69932920T2 (de) 2007-02-08
UA57824C2 (uk) 2003-07-15
HUP0100832A2 (hu) 2002-02-28
CN1177834C (zh) 2004-12-01
ES2268847T3 (es) 2007-03-16
EA200000741A1 (ru) 2001-02-26
MY133125A (en) 2007-10-31
IL137330A0 (en) 2001-07-24
ATE337307T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
MY121294A (en) Novel hexanoic acid derivatives.
BG103413A (en) Derivatives of sulphinic acid, their production and application
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
BG104597A (en) Inhibition of raf kinase using substituted heterocyclic ureas
BG101110A (en) Substituted pyrimidine compounds and their application
MX9702658A (es) Derivados novedosos de acido carboxilico, su preparacion y uso.
BG103251A (en) Oxydiazols, methods for their preparation and application as medicamentous forms
BG92804A (bg) 4-бензоилизоксазолови производни
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
YU21401A (sh) Tetrahidropiridoetri
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
MY115211A (en) Novel amino acid derivatives, their preparation and use
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
MY109722A (en) Azaoxindole derivatives.
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
ES8705448A1 (es) Procedimiento para la obtencion de derivados de piridina
ZA9410181B (en) Arylacetic acid derivatives.
BG101109A (en) Thiopyridyl compounds for controlling helicobacter bacteria
BG102814A (en) New derivatives of carboxylic acid, their preparation and application
BG104291A (en) 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання